Clinical Trial Update: Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the optimal duration of bismuth quadruple therapy for Helicobacter pylori infection, comparing outcomes in females vs males.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth quadruple therapy

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Helicobacter Pylori Infection, Sex | Phase 4 | Status: ENROLLING_BY_INVITATION